These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 30075248)

  • 21. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
    Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.
    Bahrambeigi V; Ahmadi N; Moisyadi S; Urschitz J; Salehi R; Haghjooy Javanmard S
    Mol Cancer; 2014 Nov; 13():255. PubMed ID: 25428727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
    Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
    Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
    Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
    Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
    Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
    Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p.
    Li JW; Wei L; Han Z; Chen Z
    Eur J Pharmacol; 2019 Jun; 852():68-76. PubMed ID: 30682335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
    Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
    Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells.
    Tang XJ; Lu JT; Tu HJ; Huang KM; Fu R; Cao G; Huang M; Cheng LH; Dai LJ; Zhang L
    Anticancer Res; 2014 Feb; 34(2):729-34. PubMed ID: 24511006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
    Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
    Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
    Lang FM; Hossain A; Gumin J; Momin EN; Shimizu Y; Ledbetter D; Shahar T; Yamashita S; Parker Kerrigan B; Fueyo J; Sawaya R; Lang FF
    Neuro Oncol; 2018 Feb; 20(3):380-390. PubMed ID: 29016843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.
    Luetzkendorf J; Mueller LP; Mueller T; Caysa H; Nerger K; Schmoll HJ
    J Cell Mol Med; 2010 Sep; 14(9):2292-304. PubMed ID: 19508388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci.
    de Araujo Farias V; O'Valle F; Serrano-Saenz S; Anderson P; Andrés E; López-Peñalver J; Tovar I; Nieto A; Santos A; Martín F; Expósito J; Oliver FJ; de Almodóvar JMR
    Mol Cancer; 2018 Aug; 17(1):122. PubMed ID: 30111323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy.
    Wang Z; Chen H; Wang P; Zhou M; Li G; Hu Z; Hu Q; Zhao J; Liu X; Wu L; Liang D
    Stem Cells Transl Med; 2022 Mar; 11(3):297-309. PubMed ID: 35267023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
    Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
    Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats.
    Nong K; Wang W; Niu X; Hu B; Ma C; Bai Y; Wu B; Wang Y; Ai K
    Cytotherapy; 2016 Dec; 18(12):1548-1559. PubMed ID: 27592404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Tumor Necrosis Factor-Producing Mesenchymal Stem Cells on Apoptosis of Chronic B-lymphocytic Tumor Cells Resistant to Fludarabine-based Chemotherapy.
    Valizadeh A; Ahmadzadeh A; Saki G; Khodadadi A; Teimoori A
    Asian Pac J Cancer Prev; 2015; 16(18):8533-9. PubMed ID: 26745113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma.
    Qiu Y; Sun J; Qiu J; Chen G; Wang X; Mu Y; Li K; Wang W
    Cancer Manag Res; 2020; 12():10809-10820. PubMed ID: 33149686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.